BioScrip, Inc.BioScrip, Inc. • July 9th, 2009 • Retail-drug stores and proprietary stores • Massachusetts
Reference is hereby made to that certain letter agreement, dated as of the date hereof (as amended and in effect from time to time, the “L/C Agreement”), between BioScrip, Inc. and Bank of America, N.A. (“Bank of America” or “you”), pursuant to which Bank of America has agreed to issue, amend and renew Standby Letters of Credit (all such Standby Letters of Credit so issued, amended or renewed thereunder being hereinafter referred to as the “Credits”) for the account of BioScrip, Inc. and its subsidiaries (collectively, “we” or “us”), in an aggregate face amount at any one time not to exceed $5,000,000, and all as more particularly set forth therein. All of our obligations owing by us to you hereunder or arising under or in respect of the L/C Agreement (including any L/C Application delivered under and as defined in the L/C Agreement) or any Credit, whether now existing or hereafter arising, contingent or otherwise, are hereinafter referred to, collectively, as the “Obligations”. In con
Bank of America, N.A. Boston, Massachusetts 02110BioScrip, Inc. • July 9th, 2009 • Retail-drug stores and proprietary stores
BANK OF AMERICA, N.A. (the “Lender”) is pleased to make available to BIOSCRIP, INC., a Delaware corporation (the “Borrower”), a letter of credit facility on the terms and subject to the conditions set forth below. Capitalized terms not defined herein have the meanings assigned to them in Exhibit A attached to this letter agreement (this “Agreement”).
